p120RasGAP Is a Mediator of Rho Pathway Activation and Tumorigenicity in the DLD1 Colorectal Cancer Cell Line-Reference-Cited by-同舟云学术

p120RasGAP Is a Mediator of Rho Pathway Activation and Tumorigenicity in the DLD1 Colorectal Cancer Cell Line

Published:2014-01-21 Issue:1 Volume:9 Page:e86103
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Organ Shawna L.,Hai Josephine,Radulovich Nikolina,Marshall Christopher B.,Leung Lisa,Sasazuki Takehiko,Shirasawa Senji,Zhu Chang-Qi,Navab Roya,Ikura Mitsuhiko,Tsao Ming-Sound

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference64 articles.

1. Cancer statistics, 2013;R Siegel;CA: A Cancer Journal for Clinicians,2013

2. An unsolved conundrum: the ideal follow-up strategy after curative surgery for colorectal cancer;P Sinclair;Gastrointest Endosc,2012

3. Colorectal liver metastases: an update on palliative treatment options;R Konopke;J Gastrointestin Liver Dis,2012

4. Genetic alterations during colorectal-tumor development;B Vogelstein;N Engl J Med,1988

5. American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy;CJ Allegra;J Clin Oncol,2009

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical significance of the KRAS G13D mutation in anastomotic recurrence of colorectal cancer;Oncology Letters;2023-03-28

2. Ras superfamily GTPase activating proteins in cancer: Potential therapeutic targets?;European Journal of Medicinal Chemistry;2023-02

3. miR‑188‑5p promotes oxaliplatin resistance by targeting RASA1 in colon cancer cells;Oncology Letters;2021-04-20

4. Role of RASA1 in cancer: A review and update (Review);Oncology Reports;2020-10-13

5. Investigation of the role and mechanism of ARHGAP5-mediated colorectal cancer metastasis;Theranostics;2020